Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Raly | Rat | 1,2-dimethylhydrazine | decreases expression | ISO | Raly (Mus musculus) | 6480464 | 1,2-Dimethylhydrazine results in decreased expression of RALY mRNA | CTD | PMID:22206623 | Raly | Rat | 17alpha-ethynylestradiol | decreases expression | EXP | | 6480464 | Ethinyl Estradiol results in decreased expression of RALY mRNA | CTD | PMID:29097150 | Raly | Rat | 17beta-estradiol | affects expression | ISO | Raly (Mus musculus) | 6480464 | Estradiol affects the expression of RALY mRNA | CTD | PMID:15598610 | Raly | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of RALY mRNA | CTD | PMID:22298810|PMID:34747641 | Raly | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of RALY mRNA | CTD | PMID:33387578 | Raly | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Raly (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of RALY mRNA | CTD | PMID:21570461 | Raly | Rat | 3',5'-cyclic UMP | affects binding | ISO | RALY (Homo sapiens) | 6480464 | RALY protein binds to cyclic 3',5'-uridine monophosphate | CTD | PMID:30528433 | Raly | Rat | 4,4'-sulfonyldiphenol | increases expression | ISO | RALY (Homo sapiens) | 6480464 | bisphenol S results in increased expression of RALY protein | CTD | PMID:34186270 | Raly | Rat | aconitine | decreases expression | EXP | | 6480464 | Aconitine results in decreased expression of RALY protein | CTD | PMID:33236894 | Raly | Rat | actinomycin D | multiple interactions | ISO | RALY (Homo sapiens) | 6480464 | [Dactinomycin co-treated with nutlin 3] results in increased secretion of RALY protein | CTD | PMID:38460933 | Raly | Rat | all-trans-retinoic acid | multiple interactions | ISO | RALY (Homo sapiens) | 6480464 | [sodium arsenite co-treated with Tretinoin] results in decreased expression of RALY protein | CTD | PMID:39571964 | Raly | Rat | Aroclor 1254 | decreases expression | ISO | Raly (Mus musculus) | 6480464 | Chlorodiphenyl (54% Chlorine) results in decreased expression of RALY mRNA | CTD | PMID:23650126 | Raly | Rat | arsenous acid | decreases expression | ISO | RALY (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of RALY protein | CTD | PMID:25419056 | Raly | Rat | benzo[a]pyrene | increases expression | ISO | Raly (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of RALY mRNA | CTD | PMID:20504355|PMID:22228805 | Raly | Rat | benzo[a]pyrene | affects methylation | ISO | RALY (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of RALY 5' UTR | CTD | PMID:27901495 | Raly | Rat | benzo[e]pyrene | increases methylation | ISO | RALY (Homo sapiens) | 6480464 | benzo(e)pyrene results in increased methylation of RALY intron | CTD | PMID:30157460 | Raly | Rat | beta-naphthoflavone | decreases expression | ISO | RALY (Homo sapiens) | 6480464 | beta-Naphthoflavone results in decreased expression of RALY protein | CTD | PMID:39638853 | Raly | Rat | bis(2-ethylhexyl) phthalate | increases expression | ISO | Raly (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in increased expression of RALY mRNA | CTD | PMID:33754040 | Raly | Rat | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of RALY mRNA | CTD | PMID:25181051 | Raly | Rat | bisphenol A | decreases expression | ISO | RALY (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of RALY protein | CTD | PMID:31675489|PMID:34186270 | Raly | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of RALY mRNA | CTD | PMID:34947998 | Raly | Rat | bisphenol A | increases methylation | ISO | Raly (Mus musculus) | 6480464 | bisphenol A results in increased methylation of RALY promoter | CTD | PMID:27312807 | Raly | Rat | bisphenol AF | increases expression | ISO | RALY (Homo sapiens) | 6480464 | bisphenol AF results in increased expression of RALY protein | CTD | PMID:34186270 | Raly | Rat | Bisphenol B | increases expression | ISO | RALY (Homo sapiens) | 6480464 | bisphenol B results in increased expression of RALY protein | CTD | PMID:34186270 | Raly | Rat | bisphenol F | increases expression | ISO | RALY (Homo sapiens) | 6480464 | bisphenol F results in increased expression of RALY protein | CTD | PMID:34186270 | Raly | Rat | caffeine | affects phosphorylation | ISO | RALY (Homo sapiens) | 6480464 | Caffeine affects the phosphorylation of RALY protein | CTD | PMID:35688186 | Raly | Rat | CGP 52608 | multiple interactions | ISO | RALY (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to RALY gene] | CTD | PMID:28238834 | Raly | Rat | copper(II) sulfate | decreases expression | ISO | RALY (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of RALY mRNA | CTD | PMID:19549813 | Raly | Rat | deoxynivalenol | increases expression | ISO | RALY (Homo sapiens) | 6480464 | deoxynivalenol results in increased expression of RALY protein | CTD | PMID:33890134 | Raly | Rat | diarsenic trioxide | decreases expression | ISO | RALY (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of RALY protein | CTD | PMID:25419056 | Raly | Rat | doxorubicin | increases expression | ISO | RALY (Homo sapiens) | 6480464 | Doxorubicin results in increased expression of RALY mRNA | CTD | PMID:29803840 | Raly | Rat | elemental selenium | increases expression | ISO | RALY (Homo sapiens) | 6480464 | Selenium results in increased expression of RALY mRNA | CTD | PMID:19244175 | Raly | Rat | ethanol | multiple interactions | ISO | RALY (Homo sapiens) | 6480464 | [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic more ... | CTD | PMID:29432896 | Raly | Rat | fenthion | increases expression | ISO | Raly (Mus musculus) | 6480464 | Fenthion results in increased expression of RALY mRNA | CTD | PMID:34813904 | Raly | Rat | FR900359 | affects phosphorylation | ISO | RALY (Homo sapiens) | 6480464 | FR900359 affects the phosphorylation of RALY protein | CTD | PMID:37730182 | Raly | Rat | furan | increases methylation | EXP | | 6480464 | furan results in increased methylation of RALY gene | CTD | PMID:22079235 | Raly | Rat | hexane | decreases methylation | EXP | | 6480464 | n-hexane results in decreased methylation of RALY promoter | CTD | PMID:23740543 | Raly | Rat | ivermectin | decreases expression | ISO | RALY (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of RALY protein | CTD | PMID:32959892 | Raly | Rat | lead(0) | decreases expression | ISO | RALY (Homo sapiens) | 6480464 | Lead results in decreased expression of RALY mRNA | CTD | PMID:19921347 | Raly | Rat | methamphetamine | affects response to substance | ISO | RALY (Homo sapiens) | 6480464 | RALY gene SNP affects the susceptibility to Methamphetamine | CTD | PMID:18316681 | Raly | Rat | methapyrilene | increases methylation | ISO | RALY (Homo sapiens) | 6480464 | Methapyrilene results in increased methylation of RALY intron | CTD | PMID:30157460 | Raly | Rat | methapyrilene | increases expression | EXP | | 6480464 | Methapyrilene results in increased expression of RALY mRNA | CTD | PMID:30467583 | Raly | Rat | methyl methanesulfonate | increases expression | ISO | RALY (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of RALY mRNA | CTD | PMID:23649840 | Raly | Rat | N,N-diethyl-m-toluamide | multiple interactions | EXP | | 6480464 | [Permethrin co-treated with DEET] results in decreased methylation of RALY gene | CTD | PMID:33148267 | Raly | Rat | nickel sulfate | increases expression | ISO | RALY (Homo sapiens) | 6480464 | nickel sulfate results in increased expression of RALY mRNA | CTD | PMID:18651567 | Raly | Rat | Nutlin-3 | multiple interactions | ISO | RALY (Homo sapiens) | 6480464 | [Dactinomycin co-treated with nutlin 3] results in increased secretion of RALY protein | CTD | PMID:38460933 | Raly | Rat | okadaic acid | increases expression | ISO | RALY (Homo sapiens) | 6480464 | Okadaic Acid results in increased expression of RALY mRNA; Okadaic Acid results in increased expression more ... | CTD | PMID:38832940 | Raly | Rat | paracetamol | increases expression | ISO | RALY (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of RALY mRNA | CTD | PMID:29067470 | Raly | Rat | perfluorooctanoic acid | increases expression | ISO | Raly (Mus musculus) | 6480464 | perfluorooctanoic acid results in increased expression of RALY protein | CTD | PMID:37422089 | Raly | Rat | permethrin | multiple interactions | EXP | | 6480464 | [Permethrin co-treated with DEET] results in decreased methylation of RALY gene | CTD | PMID:33148267 | Raly | Rat | pirinixic acid | multiple interactions | ISO | Raly (Mus musculus) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in more ... | CTD | PMID:19710929 | Raly | Rat | pirinixic acid | increases expression | ISO | Raly (Mus musculus) | 6480464 | pirinixic acid results in increased expression of RALY mRNA | CTD | PMID:23811191 | Raly | Rat | quercetin | increases phosphorylation | ISO | RALY (Homo sapiens) | 6480464 | Quercetin results in increased phosphorylation of RALY protein | CTD | PMID:35688186 | Raly | Rat | SB 431542 | multiple interactions | ISO | RALY (Homo sapiens) | 6480464 | [LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of RALY more ... | CTD | PMID:37664457 | Raly | Rat | selenium atom | increases expression | ISO | RALY (Homo sapiens) | 6480464 | Selenium results in increased expression of RALY mRNA | CTD | PMID:19244175 | Raly | Rat | sodium arsenite | increases expression | ISO | RALY (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of RALY mRNA | CTD | PMID:38568856 | Raly | Rat | sodium arsenite | multiple interactions | ISO | RALY (Homo sapiens) | 6480464 | [sodium arsenite co-treated with Tretinoin] results in decreased expression of RALY protein | CTD | PMID:39571964 | Raly | Rat | temozolomide | decreases expression | ISO | RALY (Homo sapiens) | 6480464 | Temozolomide results in decreased expression of RALY mRNA | CTD | PMID:31758290 | Raly | Rat | thiram | increases expression | ISO | RALY (Homo sapiens) | 6480464 | Thiram results in increased expression of RALY mRNA | CTD | PMID:38568856 | Raly | Rat | titanium dioxide | increases methylation | ISO | Raly (Mus musculus) | 6480464 | titanium dioxide results in increased methylation of RALY gene | CTD | PMID:35295148 | Raly | Rat | titanium dioxide | decreases methylation | ISO | Raly (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of RALY gene; titanium dioxide results in decreased methylation more ... | CTD | PMID:35295148 | Raly | Rat | Tributyltin oxide | increases phosphorylation | ISO | Raly (Mus musculus) | 6480464 | bis(tri-n-butyltin)oxide results in increased phosphorylation of RALY protein | CTD | PMID:22174045 | Raly | Rat | triphenyl phosphate | affects expression | ISO | RALY (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of RALY mRNA | CTD | PMID:37042841 | Raly | Rat | triptonide | decreases expression | ISO | Raly (Mus musculus) | 6480464 | triptonide results in decreased expression of RALY mRNA | CTD | PMID:33045310 | Raly | Rat | urethane | increases expression | ISO | RALY (Homo sapiens) | 6480464 | Urethane results in increased expression of RALY mRNA | CTD | PMID:28818685 | Raly | Rat | valproic acid | affects expression | ISO | RALY (Homo sapiens) | 6480464 | Valproic Acid affects the expression of RALY mRNA | CTD | PMID:25979313 | Raly | Rat | vitamin E | increases expression | ISO | RALY (Homo sapiens) | 6480464 | Vitamin E results in increased expression of RALY mRNA | CTD | PMID:19244175 | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






















